New drugs: who can afford them?

Access to Anti-Diabetic Medicines among Patients Attending Tertiary Health Facilities in Oyo State, Nigeria

Objective: The management of Diabetes Mellitus (DM) is longterm and can be expensive. This study aimed to describe access to anti-diabetic medicines among patients in tertiary health care facilities in Oyo State, Nigeria. Materials and Methods: This was a hospital-based crosssectional study. The study sites were the University College Hospital (UCH), Ibadan, and Ladoke Akintola University Teach...

National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability; Comment on “Universal Pharmacare in Canada: A Prescription for Equity in Healthcare”

Canada’s federal government intends to take steps to implement national pharmacare so that all Canadians have prescription drug coverage they need at an affordable price. Relatively limited funds have so far been pledged to support national pharmacare, which raises the question: what kind of program is envisioned? Since the government has already introduced regulations intended to reduce new dr...

#702 - Pay Dirt From The Human Genome

The 3 billion genetic instructions that form a blueprint for human life have now been cataloged, but the meaning of most of those instructions remains unknown. Therefore, the practical significance of deciphering the book of human life remains murky except in one area: many new pharmaceutical drugs will soon be possible. Unfortunately, this is a mixed blessing. A raft of new drugs may benefit t...

How to help your low-income patients get prescription drugs.

www.aafp.org / fpm ■ F A M I L Y P R A C T I C E M A N A G E M E N T ■ 51 IL LU ST R A TI O N B Y J O H N P A TR IC K Anyone who has flipped through a newspaper recently knows that the escalating cost of prescription drugs is an issue of national concern, especially as such drugs become an increasingly significant element of medical care. The problem that higher medication prices pose for the u...

Providing outpatient prescription drugs through Medicare: can we afford to? Can we afford not to?